Krempa David sold ETON
October 6, 2026 · Form 4 insider transaction
Krempa David sold 4,166 shares of Eton Pharmaceuticals, Inc. at $55.07 per share, a transaction worth $229.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,166
Price
$55.07
Total value
$229.4K
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 6, 2026
Filing dateOctober 6, 2026
Shares owned after43,381
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.; The shares were sold in multiple trades at prices ranging from $54.915 to $55.135. The price reported above reflects the weighted average sales price.